Semantic Dementia
Description
Semantic dementia (SD) is a form of frontotemporal dementia (FTD; see this term), characterized by the progressive, amodal and profound loss of semantic knowledge (combination of visual associative agnosia, anomia, surface dyslexia or dysgraphia and disrupted comprehension of word meaning) and behavioral abnormalities, attributable to the degeneration of the anterior temporal lobes.
Genes related to Semantic Dementia
- TREM2
- CHMP2B
- C9orf72
- PSEN1
- TMEM106B
- GRN
- MAPT
Clinical Features
Phenotypes and symptoms related to Semantic Dementia
- Dementia
- Neurological speech impairment
- Brain atrophy
- Aphasia
- Dyslexia
- Dysgraphia
- Abulia
- Alexia
- Visual agnosia
- Anomia
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Semantic Dementia Is also known as semantic primary progressive aphasia, semantic variant ppa.
Researches and researchers
Doctors, researchs, and experts related to Semantic Dementia extracted from public data.
Semantic Dementia Experts map
Current Researchs and researchers
-
Coordinator of expert centre - Genetic counsellor - Investigator of research projectBARCELONA — Dr Raquel SÁNCHEZ DEL VALLE DÍAZ
-
Institution/s:
— Servicio de Neurología, Hospital Clínic de Barcelona
— Neurociencia clínica y experimental, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) -
Research area/topic::
PreFrontAls: Searching for therapeutic interventions in frontotemporal dementia with C9ORF72 repeat expansions in the presymptomatic stage - ES
-
Institution/s:
Semantic Dementia Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
![]() By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).
SORL1, TARDBP, VCP, FIG4, OPTN, TREM2, CSF1R, CHMP2B, DCTN1, C9orf72, FUS, ALS2, SETX, GRN, ANG, APOE, APP, MAPT, PRNP, PSEN1 , (...)
View the complete list with 1 more genes
Specificity
29 %
Genes
86 % |
![]() By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).
SCP2, SGCE, SLC20A2, SLC2A1, SLC6A3, SPR, SUCLA2, SUOX, TAF1, TH, TIMM8A, TREX1, MCOLN1, FBXO7, CACNA1A, NPC2, PINK1, PANK2, SAMHD1, APTX , (...)
View the complete list with 57 more genes
Specificity
4 %
Genes
43 % |
![]() By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).
SCP2, SGCE, SLC20A2, SLC2A1, SLC6A3, SNCA, SPR, SQSTM1, SUCLA2, SUOX, TAF1, TH, TIMM8A, TREX1, MCOLN1, VPS35, FBXO7, CACNA1A, NPC2, PINK1 , (...)
View the complete list with 72 more genes
Specificity
5 %
Genes
58 % |
![]() By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).
TREM2
Specificity
100 %
Genes
15 % |
![]() By CGC Genetics (Portugal).
TREM2
Specificity
100 %
Genes
15 % |
![]() By CGC Genetics (Portugal).
SNCA, SNCB, SORL1, TARDBP, TIMM8A, TUBA4A, TYROBP, UBQLN2, VCP, CHCHD10, TREM2, TRPM7, CSF1R, CHMP2B, DNMT1, ATP13A2, FUS, GRN, HNRNPA1, HNRNPA2B1 , (...)
View the complete list with 8 more genes
Specificity
18 %
Genes
72 % |
![]() By PreventionGenetics PreventionGenetics (United States).
SOD1, SQSTM1, TARDBP, TBK1, UBQLN2, VAPB, VCP, OPTN, CDH13, TREM2, CHMP2B, C9orf72, ARHGEF28, FUS, SETX, GRN, ANG, HNRNPA1, HNRNPA2B1, ANXA11 , (...)
View the complete list with 5 more genes
Specificity
24 %
Genes
86 % |
![]() By PreventionGenetics PreventionGenetics (United States).
TREM2
Specificity
100 %
Genes
15 % |
You can get up to 264 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like PSEUDOHYPOALDOSTERONISM, TYPE IIA; PHA2A EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36 LETHAL CONGENITAL CONTRACTURE SYNDROME 3; LCCS3 ANGIOEDEMA, HEREDITARY, TYPE III; HAE3 AL-GAZALI-BAKALINOVA SYNDROME; AGBK BLOOD GROUP, P1PK SYSTEM GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II; CDG2